Soluble CD163 is increased in patients with acute pancreatitis independent of disease severity

Exp Mol Pathol. 2015 Oct;99(2):236-9. doi: 10.1016/j.yexmp.2015.07.006. Epub 2015 Jul 21.

Abstract

Macrophages are crucially involved in the pathophysiology of acute pancreatitis. Soluble CD163 (sCD163) is specifically released from macrophages and systemic levels are increased in inflammatory diseases. Here, sCD163 was measured in serum of 50 patients with acute pancreatitis to find out possible associations with disease activity. Admission levels of systemic sCD163 were nearly three-fold higher in patients with acute pancreatitis compared to controls. In patients sCD163 did not correlate with C-reactive protein and leukocyte count as established markers of inflammation. Levels were not associated with disease severity assessed by the Schroeder score, Balthazar score, Acute Physiology, Age, and Chronic Health Evaluation (Apache) II score and peripancreatic necrosis score. Soluble CD163 was not related to complications of acute pancreatitis. These data show that serum sCD163 is increased in acute pancreatitis indicating activation of macrophages but is not associated with disease severity and outcome.

Keywords: Acute pancreatitis; Macrophage; Peripancreatic necrosis.

Publication types

  • Comparative Study

MeSH terms

  • APACHE
  • Acute Disease
  • Antigens, CD / metabolism*
  • Antigens, Differentiation, Myelomonocytic / metabolism*
  • Biomarkers / metabolism*
  • Case-Control Studies
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatitis / metabolism*
  • Pancreatitis / pathology*
  • Receptors, Cell Surface / metabolism*
  • Severity of Illness Index*

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers
  • CD163 antigen
  • Receptors, Cell Surface